Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Vaccines for Viral Infections in Developing Countries


Thursday, July 27, 2006

8:50 AM Opening Remarks
Diane Griffin, Johns Hopkins University, USA
Harry Greenberg, Stanford University, USA
9:00 AM Overview and Major Issues for Assessment of Disease Burden of Viral Diseases in Asia (PDF)
Hitoshi Oshitani, Tohoku University, Japan

Rotavirus Session

9:45 AM Epidemiology Of Rotavirus Infection And The Need For A Vaccine In Asia (PDF)
Tony Nelson, The Chinese University of Hong Kong, China
10:15 AM Development and Implementation of Vaccine Made in the Third World (PDF)
R. Bhan, New Delhi, India
10:45 AM Break
11:00 AM Outlook for the Implementation of a Human-Bovine (UK) Rotavirus Reassortant Vaccine (PDF)
Al Kapikian, NIH, USA
11:30 AM Development and Commercial Manufacturing Challenges for Live Attenuated Rotavirus Vaccines (PDF)
W. Wainwright, Path and NIH, USA
12:00 PM Phase III Clinical Results of Rotavirus Vaccine Trials and Efforts to Accelerate Introduction to the Developing World (PDF)
John Boslego, Path, USA
12:30 PM Lunch

Human Papillomavirus Session

1:30 PM Human Papillomavirus Vaccination for Cervical Cancer Prevention (PDF)
Patti Gravitt, Johns Hopkins University, USA
2:00 PM Issues Regarding Marketing and Distribution of Vaccines in Developing Countries (PDF)
Elaine Esber, Merck, USA
2:30 PM Development of Human Papillomavirus Vaccine Against a Broader Spectrum of Oncogenic Types (PDF)
Tadahito Kanda, Japan

Rabiesvirus Session

3:00 PM Rabies Epidemiology, Disease Burden and Vaccine Utilization in Asia (PDF)
Elizabeth Miranda, Phillipines
3:30 PM Break
3:45 PM Current Vaccines and Their Availability in China (PDF)
Zhen Fu, University of Georgia, USA
4:15 PM Control of Rabies in Asia Requires Quality Biologicals and the Motivation to Use Them Appropriately (PDF)
Henry Wilde, Thai Red Cross
4:45 PM Adjourn
8:30 PM


Friday, July 28, 2006

Japanese Encephalitis Session

9:00 AM Strategy for Introduction of JE Vaccine Into Routine Immunization (PDF)
Julie Jacobson, Path, USA
9:30 AM Disease Burden Due to Japanese Encephalitis (JE) and Cost-Effectiveness of JE Immunization in Asia (PDF)
Zhi-Yi Xu, IVI, Seoul
10:00 AM Continued Transmission and Need for Booster Doses in An Endemic Country (PDF)
Eiji Konishi, Kobe University, Japan
10:30 AM Break
10:45 AM Immunological Surrogates for Japanese Encephalitis Vaccine-Induced Protection (PDF)
Ichiro Kurane, NIH Japan
11:15 AM Developing a New JE Vaccine–Switch the Mouse Brain to the Vero Cell (PDF)
Shigeharu Ueda, BIKEN Foundation, Japan
11:45 AM Inactivated SA14-14-2 (PDF)
Erich Tauber, Intercell, AG
12:15 PM Lunch
1:30 PM Safety and Efficacy of Live Attenuated Japanese Encephalitis Vaccine SA14-14-2 in Human Vaccination (PDF)
Yu Yongxin, NICBP, Beijing
2:00 PM ChimerivaxTM – A Platform Technology for Flavivirus Vaccine Development – Status of a New Vaccine Against Japanese Encephalitis (PDF)
Niranjan Kanesa-thasan, Acambis, USA

Influenza Session

2:30 PM Emergence and Continuing Evolution of H5N1 Influenza (PDF)
Robert Webster, St. Jude Hospital, USA
3:00 PM Vaccine Development for Pandemic and Seasonal Influenza (PDF)
John Treanor, University of Rochester Medical Center, USA
3:30 PM Break
3:45 PM Influenza in Asia (PDF)
Hiroshi Suzuki, Niigata University, Japan
4:15 PM Influenza Virus Patterns in Asia (PDF)
Mark Steinhoff, Johns Hopkins University, USA
4:45 PM Development Of Human Influenza H5N1 Vaccines In Japan: Research And Clinical Trials (PDF)
Masato Tashiro, National Institute of Infectious Diseases, Japan
5:15 PM Closing Remarks
Akira Oya, National Institute of Infectious Diseases, Japan

Participant List (PDF)

Last Updated March 23, 2010